Intraoperative radiation therapy for pediatric sarcomas and other solid tumors
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.30949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Brianna Conte und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Miami Miller School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Sarcoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Purpose
To evaluate local failure (LF) and toxicity after intraoperative radiation therapy (IORT) in pediatric solid tumors (ST).
Methods
A single‐institution retrospective study of 96 pediatric patients (108 applications) with ST treated from 1995 to 2022 with IORT. LF was calculated via cumulative incidence function and overall survival (OS) by Kaplan–Meier method, both from the day of surgery.
Results
Median age at time of IORT was 8 years (range: 0.8–20.9 years). Median follow‐up for all patients and surviving patients was 16 months and 3 years, respectively. The most common histologies included rhabdomyosarcoma ( n = 42), Ewing sarcoma ( n = 10), and Wilms tumor ( n = 9). Most (95%) received chemotherapy, 37% had prior external beam radiation therapy to the site of IORT, and 46% had a prior surgery for tumor resection. About half (54%) were treated with upfront IORT to the primary tumor due to difficult circumstances such as very young age or challenging anatomy. The median IORT dose was 12 Gy (range: 4–18 Gy), and median area treated was 24 cm 2 (range: 2–198 cm 2 ). The cumulative incidence of LF was 17% at 2 years and 23% at 5 years. Toxicity from IORT was reasonable, with postoperative complications likely related to IORT seen in 15 (16%) patients.
Conclusion
Our study represents the largest and most recent analysis of efficacy and safety of IORT in pediatric patients with ST. Less than one quarter of all patients failed locally with acceptable toxicities. Overall, IORT is an effective and safe technique to achieve local control in patients with challenging circumstances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Miami Miller School of Medicine, Miami, Florida, USA.
- Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: Brianna Conte, Dana L Casey, Kathryn R Tringale, Michael P LaQuaglia, Michael V Ortiz, Suzanne L Wolden
Förderung
- NCI NIH HHS
Zitieren
APA
Conte, B., Casey, D. L., Tringale, K. R., LaQuaglia, M. P., Gerstle, J. T., Wexler, L., Ortiz, M. V., & Wolden, S. L. (2024). Intraoperative radiation therapy for pediatric sarcomas and other solid tumors. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30949
Vancouver
Conte B, Casey DL, Tringale KR, LaQuaglia MP, Gerstle JT, Wexler L, et al. Intraoperative radiation therapy for pediatric sarcomas and other solid tumors. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30949
BibTeX
@article{Conte2024,
author = {Conte, Brianna and Casey, Dana L and Tringale, Kathryn R and LaQuaglia, Michael P and Gerstle, J Ted and Wexler, Leonard and Ortiz, Michael V and Wolden, Suzanne L},
title = {Intraoperative radiation therapy for pediatric sarcomas and other solid tumors},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.30949}
}
EUVIMED